We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-1.04%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.6B
AUM Growth
-$2.31B
(-5.8%)
Cap. Flow
-$309M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
3,035
New
443
Increased
1,011
Reduced
1,232
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$465M |
| 2 |
Amazon
AMZN
|
+$304M |
| 3 |
Apple
AAPL
|
+$297M |
| 4 |
Occidental Petroleum
OXY
|
+$286M |
| 5 |
Zoom
ZM
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$395M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$373M |
| 3 |
Caterpillar
CAT
|
+$297M |
| 4 |
Intel
INTC
|
+$277M |
| 5 |
NVIDIA
NVDA
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.58% |
| 2 | Healthcare | 20.45% |
| 3 | Consumer Discretionary | 10.84% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Amneal Pharmaceuticals
AMRX
$5.85B
| $966K | ﹤0.01% |
231,749
-82,200
| -26% | -$364K |
|
1652
CONMED
CNMD
$1.39B
| $966K | ﹤0.01% |
6,500
-700
| -10% | -$97.7K |
|
1653
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $965K | ﹤0.01% |
8,600
-63,800
| -88% | -$7.12M |
|
|
SAFE
1654
DELISTED
Safehold Inc.
SAFE
| $965K | ﹤0.01% |
+17,400
| New | +$1.08M |
|
1655
Frontline
FRO
$8.76B
| $964K | ﹤0.01% |
+109,500
| New | +$867K |
|
1656
Outlook Therapeutics
OTLK
$183M
| $964K | ﹤0.01% |
27,065
-17,485
| -39% | -$546K |
|
1657
Aegon
AEG
$14B
| $963K | ﹤0.01% |
+190,298
| New | +$962K |
|
1658
Harley-Davidson
HOG
$2.58B
| $961K | ﹤0.01% |
24,400
+8,600
| +54% | +$332K |
|
1659
LifeMD
LFMD
$169M
| $960K | ﹤0.01% |
271,900
-226,100
| -45% | -$803K |
|
1660
Perdoceo Education
PRDO
$1.99B
| $959K | ﹤0.01% |
83,500
+4,388
| +6% | +$48.7K |
|
1661
Cavco Industries
CVCO
$4.22B
| $956K | ﹤0.01% |
3,970
+400
| +11% | +$110K |
|
1662
Mercado Libre
MELI
$95.2B
| $952K | ﹤0.01% |
+800
| New | +$871K |
|
|
IVC
1663
DELISTED
Invacare Corporation
IVC
| $951K | ﹤0.01% |
674,156
+15,700
| +2% | +$33.6K |
|
1664
Sterling Infrastructure
STRL
$18.3B
| $949K | ﹤0.01% |
35,400
+6,600
| +23% | +$184K |
|
1665
Lineage Cell Therapeutics
LCTX
$269M
| $948K | ﹤0.01% |
615,766
-474,600
| -44% | -$736K |
|
|
INFI
1666
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $947K | ﹤0.01% |
830,500
-223,000
| -21% | -$266K |
|
1667
Stewart Information Services
STC
$2.06B
| $946K | ﹤0.01% |
15,600
| – | – |
|
1668
Tejon Ranch
TRC
$457M
| $944K | ﹤0.01% |
51,700
-20,800
| -29% | -$363K |
|
|
SEEL
1669
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $944K | ﹤0.01% |
294
-89
| -23% | -$383K |
|
|
SLCA
1670
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $944K | ﹤0.01% |
+50,600
| New | +$640K |
|
1671
Johnson Outdoors
JOUT
$491M
| $943K | ﹤0.01% |
12,134
-6,400
| -35% | -$539K |
|
1672
Upbound Group
UPBD
$1.13B
| $937K | ﹤0.01% |
37,200
+27,400
| +280% | +$990K |
|
1673
Westwater Resources
WWR
$52.4M
| $934K | ﹤0.01% |
467,000
+287,600
| +160% | +$583K |
|
1674
Sana Biotechnology
SANA
$871M
| $933K | ﹤0.01% |
112,900
+92,000
| +440% | +$744K |
|
1675
Acadia Healthcare
ACHC
$2.76B
| $931K | ﹤0.01% |
+14,200
| New | +$825K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, Two Sigma Advisers held 3,035 positions worth $37.6B, down 5.8% from $39.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers's Q1 2022 filing shows 443 new, 1,011 increased, 1,232 reduced and 320 closed positions. Its largest new stake was PepsiCo: 1,100,300 shares worth $184M. The largest sale was Coca-Cola, an estimated $395M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Two Sigma Advisers's largest Q1 2022 buy was PepsiCo: 1,100,300 shares worth $184M.
- Two Sigma Advisers added most to Adobe in Q1 2022, an estimated $465M increase.
- Two Sigma Advisers's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $395M.
- Two Sigma Advisers fully exited Activision Blizzard in Q1 2022, selling an estimated $373M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $37.6B portfolio in Q1 2022.
- Two Sigma Advisers opened 443 new positions and closed 320 in Q1 2022.
- Two Sigma Advisers's portfolio value fell 5.8% quarter-over-quarter to $37.6B.
Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.